SI No 50 of 2006 European Communities (Limitation of Effect of Patent) Regulations 2006

30th January 2006  |   SIs

Amendment to Section 42 of the Patents Act 1992 by creating an exemption from patent infringement for acts carried out by generic or biosimilar manufactures with a view to obtaining a market authorisation for a generic or biosimilar medicinal product. This is known as a Bolar type provision.

European Communities (Limitation of Effect of Patent) Regulations 2006

Published by Innovation and Investment

Topics: Intellectual Property

Back to Top